AU669713B2 - Constitutive and inducible epidermal vector systems - Google Patents

Constitutive and inducible epidermal vector systems Download PDF

Info

Publication number
AU669713B2
AU669713B2 AU42213/93A AU4221393A AU669713B2 AU 669713 B2 AU669713 B2 AU 669713B2 AU 42213/93 A AU42213/93 A AU 42213/93A AU 4221393 A AU4221393 A AU 4221393A AU 669713 B2 AU669713 B2 AU 669713B2
Authority
AU
Australia
Prior art keywords
nucleic acid
vector
cassette
acid sequence
epidermal cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42213/93A
Other languages
English (en)
Other versions
AU4221393A (en
Inventor
David A Greenhalgh
Dennis R Roop
Joseph A Rothnagel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU4221393A publication Critical patent/AU4221393A/en
Application granted granted Critical
Publication of AU669713B2 publication Critical patent/AU669713B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/32—Vector systems having a special element relevant for transcription being an silencer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Eye Examination Apparatus (AREA)
AU42213/93A 1992-04-30 1993-04-28 Constitutive and inducible epidermal vector systems Ceased AU669713B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87628692A 1992-04-30 1992-04-30
US876286 1992-04-30
PCT/US1993/003993 WO1993022431A1 (fr) 1992-04-30 1993-04-28 Systemes de vecteurs epidermiques constitutifs et inductifs

Publications (2)

Publication Number Publication Date
AU4221393A AU4221393A (en) 1993-11-29
AU669713B2 true AU669713B2 (en) 1996-06-20

Family

ID=25367356

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42213/93A Ceased AU669713B2 (en) 1992-04-30 1993-04-28 Constitutive and inducible epidermal vector systems

Country Status (5)

Country Link
EP (1) EP0644933A4 (fr)
JP (1) JPH08501202A (fr)
AU (1) AU669713B2 (fr)
CA (1) CA2134670A1 (fr)
WO (1) WO1993022431A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2152753B1 (es) * 1993-03-29 2001-09-01 Ct Investig Energeticas Ciemat Animales transgenicos para la determinacion de agentes que estimulan o reprimen la hiperproliferacion epidermica y el crecimiento del pelo
AUPM746694A0 (en) * 1994-08-15 1994-09-08 Garvan Institute Of Medical Research Expression vector
CA2213669A1 (fr) * 1995-02-25 1996-09-06 Joseph Michael Carroll Animaux transgeniques utilises comme modele du psoriasis
US6147056A (en) * 1995-06-06 2000-11-14 Trustees Of Boston University Use of locally applied DNA fragments
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
US7094766B1 (en) 1995-06-06 2006-08-22 Trustees Of Boston University Use of locally applied DNA fragments
US5955059A (en) * 1995-06-06 1999-09-21 Trustees Of Boston University Use of locally applied DNA fragments
GB2324960A (en) * 1997-05-09 1998-11-11 Univ Manchester Delivery of naked DNA for wound healing
AU2001251115A1 (en) 2000-03-31 2001-10-15 Trustees Of Boston University Use of locally applied dna fragments
US11135269B2 (en) 2013-12-11 2021-10-05 The General Hospital Corporation Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863899A (en) * 1983-05-09 1989-09-05 Todaro George J Biologically active polypeptides
DE3686304T2 (de) * 1985-04-04 1993-02-11 Univ Georgetown Typenspezifische papillomavirus-dns-sequenzen und peptide.
US4806523A (en) * 1985-08-06 1989-02-21 Collagen Corporation Method of treating inflammation
US4816464A (en) * 1987-06-22 1989-03-28 American Home Products Corporation 10-Substituted benzo[b][1,6]naphthyridines as inhibitors of interleukin 1
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
JPH02109966A (ja) * 1988-10-20 1990-04-23 Kirin Brewery Co Ltd ラジアルフロー式充填層型バイオリアクタ
US5087617A (en) * 1989-02-15 1992-02-11 Board Of Regents, The University Of Texas System Methods and compositions for treatment of cancer using oligonucleotides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FINCH ET AL: CARCINOGENESIS, VOL 12, NO 8, 1519-1522, 1991 *
ROOP ET AL: CLINICAL RESEARCH, VOL 38, NO 2, 688A, 1990 *
TOMIC ET AL: CELL REGULATION, VOL 1, 965-973, NOV 1990 *

Also Published As

Publication number Publication date
WO1993022431A1 (fr) 1993-11-11
EP0644933A1 (fr) 1995-03-29
EP0644933A4 (fr) 1997-06-25
AU4221393A (en) 1993-11-29
JPH08501202A (ja) 1996-02-13
CA2134670A1 (fr) 1993-11-11

Similar Documents

Publication Publication Date Title
AU660751B2 (en) Myogenic vector systems
Kraner et al. Silencing the type II sodium channel gene: a model for neural-specific gene regulation
CA2311643C (fr) Compositions et procedes induisant l'expression genique
Hayashi et al. Lens-specific enhancer in the third intron regulates expression of the chicken delta 1-crystallin gene.
US6143727A (en) Specific expression vectors and methods of use
AU669713B2 (en) Constitutive and inducible epidermal vector systems
Chung et al. Regulatory elements mediating transcription from the Drosophila melanogaster actin 5C proximal promoter
EP0652948B1 (fr) Creation d'un vecteur appele a cibler une expression genique dans l'epiderme d'animaux transgeniques
US6524851B1 (en) Hybrid nucleic acid molecules and vectors including β-globin regulatory elements
JPH0235091A (ja) 哺乳動物細胞における発現の制御
CA2148492C (fr) Proteine bovine pouvant etre induite thermiquement et utilisations
CN113874512A (zh) 诱导毛细胞分化的组合物和方法
US20030109678A1 (en) Methods and means for regulation of gene expression
Schaack et al. Promoter strength in adenovirus transducing vectors: down-regulation of the adenovirus E1A promoter in 293 cells facilitates vector construction
Kuo et al. Determination of a Necdin cis-Acting Element Required for Neuron-Specific Expression by Using Zebra Fish
JP2003503034A (ja) 核内ｐｐａｒレセプターを使用する発現調節システム
Alouani et al. Expression of heat shock-regulated human growth hormone genes containing or lacking introns by NIH-3T3 and wish cell lines
US5922596A (en) Promoter of the retinoic acid receptor gene for directing gene expression
Aoki et al. Functional Analysis of the Homology and Heterology Promoters in Fish-Cultured Cells
MXPA00005516A (es) Composiciones y metodos para inducir la expresion de genes
JPH08173166A (ja) 自己複製配列ｄｎａ

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired